Advertisement

GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound

Presenter: Steven E. Nissen

November 15, 2016

REGISTER for free or LOG IN to view this content

GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound

Up Next

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

More slides +

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF)

Presenter: Dirk J. van Veldhuisen

November 16, 2016

Clinical Cardiology

Clinical Pharma

Imaging

IVUS/NIRS

Presentation

AHA 2016

Country